Characterization of Circulating Tumor DNA for Genetic Assessment of solid Tumors.
Clin Pharmacol Ther
; 98(1): 16-8, 2015 Jul.
Article
em En
| MEDLINE
| ID: mdl-25858882
ABSTRACT
Personalized cancer therapy requires characterization of the current status of an individual's cancer, necessitating invasive tumor tissue biopsies at diagnosis, during treatment and at progression. Serial acquisition of solid tumor biopsies during treatment to characterize mutations related to acquired resistance may not be medically feasible. Circulating tumor DNA (ctDNA) in plasma offers a possible noninvasive "real time" tool for tumor characterization, providing accessible genetic biomarkers for cancer diagnosis, prognosis, and response to therapy.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
DNA
/
Biomarcadores Tumorais
/
Neoplasias
Limite:
Humans
Idioma:
En
Revista:
Clin Pharmacol Ther
Ano de publicação:
2015
Tipo de documento:
Article